These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12574282)

  • 1. Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors.
    Chong S; Jang D; Song X; Mahony J; Petrich A; Barriga P; Chernesky M
    J Clin Microbiol; 2003 Feb; 41(2):778-82. PubMed ID: 12574282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.
    Chernesky M; Freund GG; Hook E; Leone P; D'Ascoli P; Martens M
    J Clin Microbiol; 2007 Aug; 45(8):2434-8. PubMed ID: 17581931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay.
    Chernesky M; Jang D; Luinstra K; Chong S; Smieja M; Cai W; Hayhoe B; Portillo E; Macritchie C; Main C; Ewert R
    J Clin Microbiol; 2006 Feb; 44(2):400-5. PubMed ID: 16455891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Boyadzhyan B; Yashina T; Yatabe JH; Patnaik M; Hill CS
    J Clin Microbiol; 2004 Jul; 42(7):3089-93. PubMed ID: 15243065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised.
    Schachter J; Chow JM; Howard H; Bolan G; Moncada J
    J Clin Microbiol; 2006 Jul; 44(7):2512-7. PubMed ID: 16825373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity.
    Mahony J; Chong S; Jang D; Luinstra K; Faught M; Dalby D; Sellors J; Chernesky M
    J Clin Microbiol; 1998 Nov; 36(11):3122-6. PubMed ID: 9774550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assessment of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis using highly purified elementary bodies.
    Ikeda-Dantsuji Y; Konomi I; Nagayama A
    J Med Microbiol; 2005 Apr; 54(Pt 4):357-360. PubMed ID: 15770020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection.
    Puolakkainen M; Hiltunen-Back E; Reunala T; Suhonen S; Lähteenmäki P; Lehtinen M; Paavonen J
    J Clin Microbiol; 1998 Jun; 36(6):1489-93. PubMed ID: 9620366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.
    Gaydos CA; Theodore M; Dalesio N; Wood BJ; Quinn TC
    J Clin Microbiol; 2004 Jul; 42(7):3041-5. PubMed ID: 15243057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The verification of nucleic acid amplification testing (Gen-Probe Aptima Assay) for chlamydia trachomatis from ocular samples.
    Kowalski RP; Karenchak LM; Raju LV; Ismail N
    Ophthalmology; 2015 Feb; 122(2):244-7. PubMed ID: 25439605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs.
    Chernesky M; Jang D; Gilchrist J; Hatchette T; Poirier A; Flandin JF; Smieja M; Ratnam S
    J Clin Microbiol; 2014 Jul; 52(7):2305-10. PubMed ID: 24696024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.
    Gaydos CA; Quinn TC; Willis D; Weissfeld A; Hook EW; Martin DH; Ferrero DV; Schachter J
    J Clin Microbiol; 2003 Jan; 41(1):304-9. PubMed ID: 12517865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of performance of the Versant CT/GC DNA 1.0 assay (kPCR) for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Kerndt PR; Ferrero DV; Aynalem G; Monga D; Wang S; Zhang N; Wong C; Liggins M; Meng Q
    J Clin Microbiol; 2011 Apr; 49(4):1347-53. PubMed ID: 21307209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of results obtained by performing a second ligase chain reaction assay and PCR analysis on urine samples with positive or near-cutoff results in the LCx test for Chlamydia trachomatis.
    Castriciano S; Luinstra K; Jang D; Patel J; Mahony J; Kapala J; Chernesky M
    J Clin Microbiol; 2002 Jul; 40(7):2632-4. PubMed ID: 12089293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women.
    Chernesky MA; Jang D; Sellors J; Luinstra K; Chong S; Castriciano S; Mahony JB
    Mol Cell Probes; 1997 Aug; 11(4):243-9. PubMed ID: 9281409
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Rantakokko-Jalava K; Hokynar K; Hieta N; Keskitalo A; Jokela P; Muotiala A; Jokiranta TS; Kuusela R; Sarkkinen H; Aittoniemi J; Vuorinen T; Hakanen AJ; Puolakkainen M
    Euro Surveill; 2019 May; 24(22):. PubMed ID: 31164192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Gen-Probe APTIMA-based Neisseria gonorrhoeae and Chlamydia trachomatis confirmatory testing in a metropolitan setting of high disease prevalence.
    Munson E; Boyd V; Czarnecka J; Griep J; Lund B; Schaal N; Hryciuk JE
    J Clin Microbiol; 2007 Sep; 45(9):2793-7. PubMed ID: 17581933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of real-time PCR in detecting Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical swabs and first-voided urine specimens].
    Hamasuna R; Kawai S; Ando Y; Ito K; Kurashima M; Nishimura H; Yamaguchi T; Yoshimura M; Kobayashi T; Muratani T; Matsumoto T
    Kansenshogaku Zasshi; 2011 Jan; 85(1):1-7. PubMed ID: 21404599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.
    Chernesky MA; Martin DH; Hook EW; Willis D; Jordan J; Wang S; Lane JR; Fuller D; Schachter J
    J Clin Microbiol; 2005 Jan; 43(1):127-31. PubMed ID: 15634960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three automated nucleic acid amplification systems for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in first-void urine specimens.
    Levett PN; Brandt K; Olenius K; Brown C; Montgomery K; Horsman GB
    J Clin Microbiol; 2008 Jun; 46(6):2109-11. PubMed ID: 18400919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.